Blueprint Medicines Corporation (BPMC) vs Ultragenyx Pharmaceutical Inc. (RARE)
Detailed comparison between Blueprint Medicines Corporation, Ultragenyx Pharmaceutical Inc..Total Return (%)
Blueprint Medicines Corporation (BPMC)Ultragenyx Pharmaceutical Inc. (RARE)
Which stock do you think will perform better?
Blueprint Medicines Corporation
BPMC
Ultragenyx Pharmaceutical Inc.
RARE
| Metric | Blueprint Medicines Corporation (BPMC) | Ultragenyx Pharmaceutical Inc. (RARE) |
|---|---|---|
| Current Price | $97.17 | $35.11 |
| Change | -1.59 (-1.61%) | -0.87 (-2.42%) |
| Market Cap | $6.28B | $3.32B |
| Trailing P/E | 0.00 | 0.00 |
| Forward P/E | -103.37 | -6.87 |
| Dividend Yield | 0.00% | 0.00% |
| 52-Week High | $121.90 | $60.37 |
| 52-Week Low | $73.04 | $29.59 |
| Beta | 0.00 | 0.00 |
| Earnings Per Share | $-2.51 | $-6.29 |
Processing data. Please try again later.
Average Return
| Symbol | 1 Month | Year-to-date | 1 Year | 5 Years | 10 Years | Max |
|---|---|---|---|---|---|---|
| BPMC | 20.20% | -5.99% | -10.07% | 49.31% | 289.38% | 289.38% |
| RARE | 2.84% | -18.65% | -14.28% | -47.88% | -47.77% | -47.77% |